Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 5;37(8):1698-1714.e5.
doi: 10.1016/j.cmet.2025.06.009. Epub 2025 Jul 14.

Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communication

Affiliations

Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communication

Jason C L Tong et al. Cell Metab. .

Abstract

Pancreatic alpha cells modulate beta cell function in a paracrine manner through the release of glucagon. However, the detailed molecular architecture underlying alpha-to-beta cell regulation remains poorly characterized. Here, we show that the glucagon-like peptide-1 receptor (GLP1R) is enriched as nanodomains on beta cell membranes that contact alpha cells, in keeping with increased single-molecule transcript expression. At low glucose, beta cells next to alpha cells directly sense micromolar glucagon release by pre-internalizing GLP1R. Pre-internalized GLP1R is associated with earlier beta cell Ca2+ responses to high glucose, which are then propagated across the islet. Beta cells adjacent to alpha cells are more secretory than beta cells next to other beta cells. Localized GLP1R signaling occurs in vitro and in vivo, is operative in the post-prandial state, and GLP1R contacts decrease between beta cells and alpha cells during metabolic stress. Thus, we detail a regulated pathway through which glucagon modulates insulin release.

Keywords: Ca(2+); GLP1R; alpha cell; beta cell; diabetes; glucagon; insulin; islet; pancreas; signaling.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.C., A.E., and C.Ä. are employees of Novo Nordisk A/S. J.E.C. has received funding for research from Eli Lilly, Novo Nordisk, Merck, Structure Therapeutics, Fractyl Therapeutics, Alticore, and Prostasis. J.E.C. has served as a consultant/advisory in the past 12 months with Arrowhead Therapeutics, Boehringer Ingelheim, Neurocrine Biosciences, Protagonist Therapeutics, Prostasis, and Structure Therapeutics. A. Kleinridders has received speaker’s fees from Novo Nordisk A/S and Daiichi Sankyo. D.J.H. and J.B. have filed a patent on GLP1R and GIPR chemical probes. D.J.H. and J.B. receive licensing revenue from Celtarys Research for provision of GLP1R/GIPR chemical probes. D.J.H., A.H.S. and K.V. have filed patents related to type 2 diabetes therapy and GLP1R agonism.

References

    1. Dolenšek J, Rupnik MS, and Stožer A (2015). Structural similarities and differences between the human and the mouse pancreas. Islets 7, e1024405. - PMC - PubMed
    1. Sasson A, Rachi E, Sakhneny L, Baer D, Lisnyansky M, Epshtein A, and Landsman L (2016). Islet Pericytes Are Required for β-Cell Maturity. Diabetes 65, 3008–3014. - PubMed
    1. Gan WJ, Do OH, Cottle L, Ma W, Kosobrodova E, Cooper-White J, Bilek M, and Thorn P (2018). Local Integrin Activation in Pancreatic β Cells Targets Insulin Secretion to the Vasculature. Cell Rep. 24, 2819–2826.e2813. - PubMed
    1. Adams MT, Dwulet JM, Briggs JK, Reissaus CA, Jin E, Szulczewski JM, Lyman MR, Sdao SM, Kravets V, Nimkulrat SD, et al. (2021). Reduced synchroneity of intra-islet Ca(2+) oscillations in vivo in Robo-deficient beta cells. Elife 10, e61308. - PMC - PubMed
    1. Jevon D, Deng K, Hallahan N, Kumar K, Tong J, Gan WJ, Tran C, Bilek M, and Thorn P (2022). Local activation of focal adhesion kinase orchestrates the positioning of presynaptic scaffold proteins and Ca2+ signalling to control glucose-dependent insulin secretion. eLife 11, e76262. - PMC - PubMed

LinkOut - more resources